MedPath

Illness Related Distress in Women With Clinically Localized Cutaneous Melanoma

Completed
Conditions
Melanoma
Interventions
Behavioral: questionnaire on-line or if uncomfortable with a computer interface, paper copies will be provided
Registration Number
NCT00745862
Lead Sponsor
Memorial Sloan Kettering Cancer Center
Brief Summary

The purpose of this study is to examine the experiences and quality of life of women who have been treated for melanoma. By quality of life, we mean how they are feeling about different aspects of their life. In this study, we are especially interested in their feelings about survival, physical appearance and any family concerns. We will administer a series of QOL questionnaires, data sheets with many questions, to get their response to measure their feelings about these issues.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
118
Inclusion Criteria
  • Age 18 years or older
  • Clinically node-negative primary cutaneous melanoma.
  • Patients participating must be female
  • Patients must have completed surgical treatment for melanoma at least 10 days ago and less than 2 years at the time of study entry.
Read More
Exclusion Criteria
  • Prior history of cancer with the exception of squamous or basal cell carcinoma of the skin.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
1questionnaire on-line or if uncomfortable with a computer interface, paper copies will be providedfemale patients undergoing surgical treatment of cutaneous melanoma within two years of diagnosis and treatment
Primary Outcome Measures
NameTimeMethod
To measure illness related distress regarding survival, family planning and functioning, and aesthetic satisfaction and QOL in post-surgical female patients diagnosed with clinically localized primary cutaneous melanoma.conclusion of study
Secondary Outcome Measures
NameTimeMethod
To examine the impact of illness related distress on QOL in women treated for clinically localized primary cutaneous melanoma.conclusion of study

Trial Locations

Locations (1)

Memorial Sloan-Kettering Cancer Center

🇺🇸

New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath